adagrasib
mirati
['sclc', 'adagrasib', 'nsclc', 'mirati']
mirati hoping to set apart adagrasib in competitive kras-mutant nsclc market with cns activity data. the drugmaker said it will push to add the latest cns activity data presented at asco to its regulatory application already with the fda. 